Reckon Health Care Holdings Ltd (AU:GGR)
ASX:GGR
Want to see AU:GGR full AI Analyst Report?
Top Page
Reckon Health Care Holdings Ltd
(Sydney:GGR)
Select Model
Select Model
Rating:46Neutral
Price Target:
AU$0.24
▲(17.50% Upside)
Action:ReiteratedDate:03/12/26
The score is primarily held down by very weak financial performance (losses, minimal revenue, and ongoing cash burn). Technical indicators provide some near-term support, but valuation remains challenged due to negative earnings and no provided dividend yield.
Positive Factors
Modest leverage
Relatively low debt (debt-to-equity ~0.33 in 2025) reduces near-term solvency and interest burden, giving management more flexibility to raise time and prioritize restructuring or product development. This durable balance-sheet attribute lowers refinancing pressure over the next several months.
Negative Factors
Persistent net losses
Sustained net losses through 2021–2025 indicate structural inability to cover costs from operations. Continued losses erode shareholder equity, limit reinvestment, and make future profitability dependent on significant operational change or external funding—risks that persist beyond short-term market cycles.
Read all positive and negative factors
Positive Factors
Negative Factors
Modest leverage
Relatively low debt (debt-to-equity ~0.33 in 2025) reduces near-term solvency and interest burden, giving management more flexibility to raise time and prioritize restructuring or product development. This durable balance-sheet attribute lowers refinancing pressure over the next several months.
Read all positive factors
Reckon Health Care Holdings Ltd (GGR) vs. iShares MSCI Australia ETF (EWA)
Market Cap
N/A
Dividend YieldN/A
Average Volume (3M)299.00K
Price to Earnings (P/E)―
Beta (1Y)0.73
Revenue GrowthN/A
EPS GrowthN/A
CountryAU
Employees1
SectorBasic Materials
Sector Strength58
IndustryOther Precious Metals
Share Statistics
EPS (TTM)-0.02
Shares Outstanding140,024,220
10 Day Avg. Volume126,568
30 Day Avg. Volume298,997
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)14.06
Price to Sales (P/S)0.00
P/FCF Ratio-30.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Reckon Health Care Holdings Ltd Business Overview & Revenue Model
Company Description
Golden Globe Resources Ltd, a minerals exploration company, focuses on identifying and developing of copper and gold assets in Australia. Its propertes holds 100% interest in the Dooloo Creek Project comprises two granted exploration permits cover...
Reckon Health Care Holdings Ltd Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
38
Negative
Cash Flow
20
Very Negative
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 7.64K | 0.00 | 7.18K |
| Gross Profit | 0.00 | 0.00 | 7.64K | 0.00 | 7.18K |
| EBITDA | 0.00 | 0.00 | -1.20M | -1.20M | -1.40M |
| Net Income | -1.81M | -1.16M | -1.39M | -1.49M | -1.44M |
Balance Sheet | |||||
| Total Assets | 2.55M | 2.35M | 2.96M | 3.69M | 3.63M |
| Cash, Cash Equivalents and Short-Term Investments | 261.65K | 1.36K | 189.50K | 1.07M | 1.11M |
| Total Debt | 389.86K | 253.00K | 0.00 | 37.50K | 106.50K |
| Total Liabilities | 1.38M | 678.14K | 205.41K | 119.17K | 238.97K |
| Stockholders Equity | 1.18M | 1.67M | 2.75M | 3.57M | 3.39M |
Cash Flow | |||||
| Free Cash Flow | -546.49K | -479.95K | -1.28M | -1.71M | -2.48M |
| Operating Cash Flow | -482.67K | -373.72K | -1.08M | -1.16M | -1.46M |
| Investing Cash Flow | -47.70K | 110.08K | -329.26K | -557.37K | -1.49M |
| Financing Cash Flow | 790.65K | 75.50K | 530.73K | 1.68M | 3.61M |
Reckon Health Care Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
Performance Comparison
Reckon Health Care Holdings Ltd Corporate Events
Golden Globe drills strong copper-gold hits at Dooloo Creek
May 5, 2026
Golden Globe Resources has reported encouraging assay results from its Phase 1 diamond drilling program at the Dooloo Creek project in Queensland, with significant copper and gold mineralisation intersected at the Northern Gold and Eastern Breccia...
Golden Globe Resources Advances Drilling and Expands NSW Footprint
Apr 30, 2026
Golden Globe Resources reported progress across its Australian gold and copper portfolio in the March quarter, completing Phase 1 drilling at its Dooloo Creek project in Queensland with assay results pending. The company also advanced exploration ...
Golden Globe Resources Starts Drilling at Neila Creek as Dual Exploration Push Builds
Mar 3, 2026
Golden Globe Resources has begun a Phase 1 diamond drilling program at its Neila Creek project in central New South Wales, targeting interpreted gold and copper mineralisation in an early-stage tenement within the Lachlan Fold Belt. The three-hole...
Golden Globe Resources Cancels 750,000 Restricted Options by Agreement
Mar 2, 2026
Golden Globe Resources has announced the cessation of 750,000 restricted options expiring on 31 October 2027, following a cancellation agreed between the company and the option holders. The move slightly reduces the company’s potential futur...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.